GSK Approved on two Cancer Drugs in EU

GSK have received positive feedback from the European Medicines Agency in their application to marketing authorisation for two cancer drugs, reports the Pharmaceutical Business Review.

One drug is used to treat unresectable or metastatic melanomas, whilst the other is to be used as a treatment for breast cancer along with chemotherapy. Both drugs are to be used by adults rather than children.

Dr Raphael Amado, GSK’s head of Oncology, calls the news representative “of [GSK’s] commitment to patients living with cancer.” The drugs were involved in five clinical monotherapy trials, performed on over 500 people with cancer.

Are you seeking a job in the clinical sector? Click here to search our jobs now

Clinical Jobs     Pharmaceutical Jobs

zp8497586rq
Posted in: Industry News, News
CK Logo in place of featured image